enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Sipuleucel-T - Wikipedia

   en.wikipedia.org/wiki/Sipuleucel-T

   Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP). [ 1 ] [ 3 ] [ 4 ] It is an autologous cellular immunotherapy.

3. Dendreon - Wikipedia

   en.wikipedia.org/wiki/Dendreon

   Dendreon Pharmaceuticals LLC is a biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.It consists of a mixture of the patient's own blood cells (autologous, with dendritic cells thought to be the most important) that have been incubated with the Dendreon PAP-GM-CSF fusion protein.

4. Cancer immunotherapy - Wikipedia

   en.wikipedia.org/wiki/Cancer_immunotherapy

   Sipuleucel-T (Provenge) was approved for treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer in 2010. The treatment consists of removal of antigen-presenting cells from blood by leukapheresis and growing them with the fusion protein PA2024 made from GM-CSF and prostate-specific prostatic acid ...

5. A closer look at Dendreon's new prostate cancer treatment - AOL

   www.aol.com/2009/04/28/a-closer-look-at...

   Two weeks ago, Dendreon Corp. (DNDN) reported that its experimental prostate cancer treatment, the therapeutic vaccine Provenge, was significantly successful in prolonging patient survival, but ...

6. Tackling Cancer: Prostate Cancer's Biggest Current and ... - AOL

   www.aol.com/news/2013-03-05-tackling-cancer...

   Although cancer deaths per 100,000 people have been on the downswing since 1991 thanks to access to more effective medications and better awareness about the Tackling Cancer: Prostate Cancer's ...

7. Can Dendreon Cure Its 52-Week-Low Woes? - AOL

   www.aol.com/2012/06/05/can-dendreon-cure-its-52...

   Shares of Dendreon (NAS: DNDN) hit a 52-week low yesterday. Let's take a look at how the company got here to find out whether cloudy skies remain on the horizon. How it got here Anyone following ...